Effect of patient characteristics on the efficacy and safety of imeglimin monotherapy in Japanese patients with type 2 diabetes mellitus: A post‐hoc analysis of two randomized, placebo‐controlled trials

AIMS/INTRODUCTION: Substantial variability in demographic and clinical characteristics exists among patients with type 2 diabetes mellitus, which may impact treatment. This post‐hoc analysis evaluated the efficacy and safety of imeglimin 1,000 mg twice daily (BID) monotherapy in type 2 diabetes mell...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagi, Katsuhiko, Kochi, Kenji, Watada, Hirotaka, Kaku, Kohei, Ueki, Kohjiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445191/
https://www.ncbi.nlm.nih.gov/pubmed/37264517
http://dx.doi.org/10.1111/jdi.14035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10445191/
https://www.ncbi.nlm.nih.gov/pubmed/37264517
http://dx.doi.org/10.1111/jdi.14035

Ejemplares similares